Your browser doesn't support javascript.
loading
Genetics and metabolic deregulation following cancer initiation: A world to explore
Araldi, Rodrigo Pinheiro; Módolo, Diego Grando; Sá Júnior, Paulo Luiz de; Consonni SR; Carvalho, Rodrigo Franco de; Roperto FP; Beçak, Willy; Stocco RC.
Afiliación
  • Araldi, Rodrigo Pinheiro; Instituto Butantan. Laboratório de Genética.
  • Módolo, Diego Grando; Instituto Butantan. Laboratório de Genética.
  • Sá Júnior, Paulo Luiz de; Instituto Butantan. Laboratório de Genética.
  • Consonni SR; Instituto Butantan. Laboratório de Genética.
  • Carvalho, Rodrigo Franco de; Instituto Butantan. Laboratório de Genética.
  • Roperto FP; Instituto Butantan. Laboratório de Genética.
Biomed. Pharmacother ; 82: p. 449-458, 2016.
Article | SES-SP, SESSP-IBPROD, SES-SP | ID: but-ib14540
Biblioteca responsable: BR78.1
Ubicación: BR78.1
ABSTRACT
Cancer is a group of highly complex and heterogeneous diseases with several causes. According to the stochastic model, cancer initiates from mutation in somatic cells, leading to genomic instability and cell transformation. This canonical pathway of carcinogenesis is related to the discovery of important mechanisms that regulate cancer initiation. However, there are few studies describing genetic and metabolic alterations that deregulate transformed cells, resulting in epithelial-mesenchymal transition (EMT) and its most dramatic consequence, the metastasis. This review summarizes the main genetics and metabolic changes induced by reactive oxygen species (ROS) that lead to EMT. (C) 2016 Elsevier Masson SAS. All rights reserved.
Asunto(s)

Texto completo: 1 Colección: 06-national / BR Base de datos: SES-SP / SESSP-IBPROD Asunto principal: Genética / Oncología Médica Revista: Biomed. Pharmacother Año: 2016 Tipo del documento: Article

Texto completo: 1 Colección: 06-national / BR Base de datos: SES-SP / SESSP-IBPROD Asunto principal: Genética / Oncología Médica Revista: Biomed. Pharmacother Año: 2016 Tipo del documento: Article